Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 and was first reported in December 2019 in Wuhan, China. Since then, it caused a global pandemic with 212,324,054 confirmed cases and 4,440,840 deaths worldwide as of August 22, 2021. The disease spectru...
Main Authors: | Amangurbanova, M. (Author), Rajai, N. (Author), Welty, F.K (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Online Access: | View Fulltext in Publisher |
Similar Items
-
Treatment of coronavirus disease 2019: a comprehensive review
by: Damla Sosyal, et al.
Published: (2020-11-01) -
Cardiovascular Complications in Coronavirus Disease-2019: The Understanding Continues to Evolve
by: Manish Bansal, et al.
Published: (2021-01-01) -
N-acetylcysteine and coronavirus disease 2019: May it work as a beneficial preventive and adjuvant therapy? A comprehensive review study
by: Najmolsadat Atefi, et al.
Published: (2020-01-01) -
Renal complications in coronavirus disease 2019: a systematic review
by: Taichiro Minami, et al.
Published: (2020-12-01) -
Cardiovascular Implications of Coronavirus Disease 2019
by: Rissa Ummy Setiani
Published: (2020-05-01)